Marini F, Carbonell Sala S, Falchetti A, Caramelli D, Brandi M L
Regional Center for Hereditary Endocrine Tumours, Department of Internal Medicine, University of Florence, Florence, Italy.
J Endocrinol Invest. 2008 Oct;31(10):905-9. doi: 10.1007/BF03346440.
Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant inherited endocrine cancer syndrome characterised by parathyroid, pancreas, and anterior pituitary tumors. The disease responsible gene, MEN1, was identified in 1997 and localizes to chromosome 11q13 in a minimal 600 kb interval between PYGM and D11S449 loci. About 10-20% of MEN1 patients do not have any mutation in the coding region and/or in the exon-intron junctions of the MEN1 gene. In this case, familial haplotype analysis of the 11q13 region, in at least two generations of affected members, is the only possible genetic ascertainment of the disease. We performed a microsatellite haplotype analysis at 11q13 region in 8 living and 1 deceased member of a MEN1 Italian family without any detected germline mutation of the MEN1 gene. The application of forensic techniques for ancient DNA analysis made it possible to identify the familial disease-associated haplotype and demonstrated that MEN1 disease haplotype family history can be reconstructed even when one or more family members are deceased. Identification of MEN1 disease haplotype is helpful in the clinical management of patients and relatives in families without any mutation of the MEN1 gene. Genetic screening allows the identification of individuals who are at risk before the development of clinical symptoms, limiting invasive annual cancer surveillance only to genetically positive individuals and making it possible to avoid further clinical screenings in non-carriers.
1型多发性内分泌肿瘤(MEN1)是一种罕见的常染色体显性遗传性内分泌癌综合征,其特征为甲状旁腺、胰腺和垂体前叶肿瘤。致病基因MEN1于1997年被鉴定出来,定位于11号染色体q13区,位于PYGM和D11S449基因座之间最小600 kb的区间内。约10%-20%的MEN1患者在MEN1基因的编码区和/或外显子-内含子连接区没有任何突变。在这种情况下,对至少两代受影响成员进行11q13区域的家族单倍型分析是确定该疾病唯一可行的遗传学方法。我们对一个意大利MEN1家族的8名在世成员和1名已故成员进行了11q13区域的微卫星单倍型分析,该家族未检测到MEN1基因的种系突变。应用法医技术进行古DNA分析使得识别与家族疾病相关的单倍型成为可能,并证明即使有一个或多个家庭成员去世,也可以重建MEN1疾病单倍型家族史。识别MEN1疾病单倍型有助于对MEN1基因无任何突变的家族中的患者及其亲属进行临床管理。基因筛查能够在临床症状出现之前识别出有风险的个体,仅对基因检测呈阳性的个体进行侵入性的年度癌症监测,并避免对非携带者进行进一步的临床筛查。